CCND1 and ovarian carcinoma: In agreement with the accumulation of ovarian cancer cells in G1 observed upon KI treatment (Fig. 2), we noticed a significant and reproducible decrease in cyclin D1 protein levels in the different ovarian cancer cell lines tested (Fig. 3e,f; for the original blots, please see Supplementary Fig. 8B).